Press release
Nephrology Drugs Global Market Report 2024 Global Market Analysis, Trends, Growth, Research And Forecast 2033
Nephrology Drugs Global Market
According to The Business Research Company's, The nephrology drugs market size has grown strongly in recent years. It will grow from $16.18 billion in 2023 to $17.08 billion in 2024 at a compound annual growth rate (CAGR) of 5.6%. The growth in the historic period can be attributed to rising prevalence of chronic kidney diseases (ckd), advancements in drug development, increasing awareness and diagnosis, government initiatives and healthcare policies, increasing incidence of diabetes.
The nephrology drugs market size is expected to see strong growth in the next few years. It will grow to $21.53 billion in 2028 at a compound annual growth rate (CAGR) of 6.0%. The growth in the forecast period can be attributed to emerging therapies and drug innovations, precision medicine and personalized treatment approaches, increasing healthcare expenditure, telehealth and remote patient monitoring, global health initiatives. Major trends in the forecast period include collaborations and partnerships, technological advancements in dialysis, advancements in treatment modalities, growing emphasis on early diagnosis and intervention, technological integration in nephrology management.
Get The Complete Scope Of The Report @
https://www.thebusinessresearchcompany.com/report/nephrology-drugs-global-market-report
Market Drivers and Trends:
The rising prevalence of chronic kidney disease is expected to propel the growth of the nephrology drugs market going forward. Chronic kidney disease (CKD) refers to damaged kidneys that are unable to filter blood as effectively as they should. because kidney damage develops gradually over a lengthy period of time. Wastes could accumulate in the body as a result of this injury. Nephrology drugs are primarily used in the treatment of chronic kidney disease to enhance kidney function and slow the disease, preventing it from doing more harm to the body, so these factors boost the nephrology drug market. For instance, in July 2022, according to reports shared by the Centers for Disease Control and Prevention (CDC), a US-based health protection agency, it was estimated that in the US, more than 37 million people were diagnosed with chronic kidney disease, which is more common in people aged 65 years or older (38 percent). Furthermore, according to the Kidney Foundation of Canada, a Canada-based non-profit organization, 4 million Canadians are suffering from kidney diseases. 35 percent of diabetic patients are the leading cause of kidney failure. These numbers are expected to rise in the future. Therefore, the rising prevalence of chronic kidney disease is driving the growth of the nephrology drug market.
Product innovation is a key trend gaining popularity in the nephrology drug market. Major companies operating in the nephrology drug market are innovating new products and drugs to sustain their position in the market. For instance, in March 2022, Zydus Lifesciences Limited., an Indian-based pharmaceutical company, launched OxemiaTM (desidustat) for chronic kidney disease (CKD). It is an oral, small-molecule hypoxia-inducible factor-prolyl hydroxylase (HIF-PH) inhibitor with a convenient therapeutic option for the treatment of anemia. And approved by the Drug Controller General of India. in Phase III clinical trials It demonstrated good safety profiles, hepcidin downregulation, better iron mobilization, and a reduction in LDL-C in chronic kidney disease patients. Also, by providing treatment at a reasonable price and enhancing patients quality of life, this will lessen the burden of disease.
Key Benefits for Stakeholders:
• Comprehensive Market Insights: Stakeholders gain access to detailed market statistics, trends, and analyses that help them understand the current and future landscape of their industry.
• Informed Decision-Making: The reports provide crucial data that support strategic decisions, reducing risks and enhancing business planning.
• Competitive Advantage: With in-depth competitor analysis and market share information, stakeholders can identify opportunities to outperform their competition.
• Tailored Solutions: The Business Research Company offers customized reports that address specific needs, ensuring stakeholders receive relevant and actionable insights.
• Global Perspective: The reports cover various regions and markets, providing a broad view that helps stakeholders expand and operate successfully on a global scale.
Ready to Dive into Something Exciting? Get Your Free Exclusive Sample of Our Research Report @
https://www.thebusinessresearchcompany.com/sample.aspx?id=10076&type=smp
Major Key Players of the Market:
AstraZeneca plc; AbbVie Inc.; Akebia Therapeutics Inc.; Amgen Inc.; F. Hoffmann-La Roche AG; FibroGen Inc.; Johnson And Johnson; Pfizer Inc.; GlaxoSmithKline plc; Teva Pharmaceutical Industries Limited; Boehringer Ingelheim International GmbH; Reata Pharmaceuticals Inc.; Ardelyx Inc.; Novo Nordisk A/S; Novartis AG; Baxter International Inc.; Bristol Myers Squibb Company; Kissei Pharmaceutical Co. Ltd.; Kyowa Kirin Co. Ltd.; Mallinckrodt Pharmaceuticals; OPKO Health Inc.; Sanofi S.A.; Takeda Pharmaceutical Company Limited; Vifor Pharma Group; Bayer AG; Amicus Therapeutics; Chugai Pharmaceutical Co. Ltd.; Otsuka Pharmaceutical Co. Ltd.; Mylan N.V.; Endo Pharmaceuticals plc
Nephrology Drugs Market 2024 Key Insights:
• The nephrology drugs market will grow to $21.53 billion in 2028 at a compound annual growth rate (CAGR) of 6.0%.
• Addressing The Silent Epidemic The Growing Prevalence Of Chronic Kidney Disease Fuels Expansion In The Nephrology Drugs Market
• Zydus Lifesciences Introduces Oxemiatm A Novel Hif-Ph Inhibitor Elevating Treatment Options In The Nephrology Drug Market
• North America was the largest region in the nephrology drug market in 2023
We Offer Customized Report, Click @
https://www.thebusinessresearchcompany.com/Customise?id=10076&type=smp
Contact Us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
Email: info@tbrc.info
Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Learn More About The Business Research Company
The Business Research Company (www.thebusinessresearchcompany.com) is a leading market intelligence firm renowned for its expertise in company, market, and consumer research. With a global presence, TBRC's consultants specialize in diverse industries such as manufacturing, healthcare, financial services, chemicals, and technology, providing unparalleled insights and strategic guidance to clients worldwide.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Nephrology Drugs Global Market Report 2024 Global Market Analysis, Trends, Growth, Research And Forecast 2033 here
News-ID: 3747862 • Views: …
More Releases from The Business research company
Seed Treatment Fungicides Market to Grow at 9.3% CAGR, Reaching $3.15 Billion by …
Use ONLINE30 for 30% savings on global market reports and stay on top of tariff updates, market trends, and economic shifts worldwide.
Seed Treatment Fungicides Market Outlook: How is the Market Expected to Grow by 2025?
Over the past few years, the market for seed treatment fungicides has seen robust growth. Its market value is projected to rise from $2.07 billion in 2024 to $2.21 billion in 2025, signifying a compound annual…
Rheology Modifiers Market Growth to be Driven by Emerging Trends | $10.92 Billio …
Stay informed on tariff shifts, macro trends, and global economic changes-use code ONLINE30 to enjoy 30% off our global market reports.
What is the Projected Market Size of the Rheology Modifiers Industry?
There has been a consistent expansion in the size of the rheology modifiers market in the past few years. The market, which was worth $8.59 billion in 2024, is projected to increase to $8.89 billion in 2025, demonstrating a compound…
Polyurethane Foam Market to Record 8.4% CAGR Growth Through 2029 | Global Analys …
Use ONLINE30 for 30% savings on global market reports and stay on top of tariff updates, market trends, and economic shifts worldwide.
Polyurethane Foam Market Outlook: How is the Market Expected to Grow by 2025?
In recent years, the size of the polyurethane foam market has experienced substantial growth. It is projected to increase from a value of $54.27 billion in 2024 to $57.26 billion in 2025, indicating a compound annual growth…
Pharmaceutical Intermediates Market Size to Reach $46.04 Billion by 2029 | Growt …
Stay informed on tariff shifts, macro trends, and global economic changes-use code ONLINE30 to enjoy 30% off our global market reports.
What is the Projected Market Size of the Pharmaceutical Intermediates Industry?
There has been consistent growth in the market size of pharmaceutical intermediates over the past few years. The market is predicted to increase from a value of $33.37 billion in 2024, up to $34.95 billion in 2025, with a compound…
More Releases for Nephrology
2025-2031: Nephrology EMR Software Market Trend And Analysis
On 2025-1-3 Global Info Research released【Global Nephrology EMR Software Market 2025 by Manufacturers, Regions, Type and Application, Forecast to 2031】. This report includes an overview of the development of the Nephrology EMR Software industry chain, the market status of Consumer Electronics (Nickel-Zinc Ferrite Core, Mn-Zn Ferrite Core), Household Appliances (Nickel-Zinc Ferrite Core, Mn-Zn Ferrite Core), and key enterprises in developed and developing market, and analysed the cutting-edge technology, patent, hot…
Poor Lifestyle Choices Driving Growth in Nephrology Drugs Market
𝐀𝐜𝐜𝐞𝐬𝐬 𝐭𝐡𝐞 𝐅𝐮𝐥𝐥 𝐑𝐞𝐩𝐨𝐫𝐭 @https://www.alliedmarketresearch.com/nephrology-drugs-market-A13396
The global nephrology drugs market has shown a strong growth trajectory, with a valuation of $14,501.75 million in 2020, and it is projected to reach $23,405.42 million by 2030. This growth represents a compound annual growth rate (CAGR) of 5.0% from 2021 to 2030. A variety of factors contribute to the expansion of this market, ranging from rising cases of kidney failure to advancements in renal…
Nephrology Fiber Lasers Market Size 2024 to 2031.
Market Overview and Report Coverage
Nephrology fiber lasers are medical devices used in urology procedures for the treatment of kidney stones and other kidney-related conditions. These lasers offer precision and efficiency in targeting and breaking down kidney stones, resulting in less invasive procedures and faster recovery times for patients.
The Nephrology Fiber Lasers Market is expected to experience significant growth in the coming years, with a projected CAGR of 11.60%…
Nephrology Lasers Market Size 2024 to 2031.
Market Overview and Report Coverage
Nephrology lasers refer to medical devices that are used in the treatment of kidney-related conditions using laser technology. These devices are increasingly being adopted in the field of nephrology due to their precision and effectiveness in various procedures such as lithotripsy, ablation, and incision.
The future outlook of the Nephrology Lasers Market looks promising, with a projected growth rate of 7.50% during the forecasted period.…
Nephrology Stents And CathetersMarket Size, Share, Development by 2024
Global Info Research offers a latest published report on Nephrology Stents And CathetersMarket Analysis and Forecast 2019-2025 delivering key insights and providing a competitive advantage to clients through a detailed report. This report focuses on the key global Nephrology Stents And Cathetersplayers, to define, describe and analyze the value, market share, market competition landscape, SWOT analysis and development plans in next few years.
To analyze the Nephrology Stents And Catheterswith respect…
20th Edition of International Conference on Clinical Nephrology
20th Edition of International Conference on Clinical Nephrology focuses on the undiscovered phases of Nephrology look into which gives a peerless opportunity to researchers everywhere throughout the world to take an interest, share and distinguish new considerations and furthermore exploration work. Our theme "Exploring the new technologies in Clinical Nephrology” centres on understanding the obscure realities of the Nephrology and its research. The two day conference clinches the workshops and…
